0001232524-16-000205.txt : 20160229 0001232524-16-000205.hdr.sgml : 20160229 20160229193659 ACCESSION NUMBER: 0001232524-16-000205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc CENTRAL INDEX KEY: 0001232524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981032470 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4TH FLOOR, CONNAUGHT HOUSE STREET 2: ONE BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 353-1-634-7800 MAIL ADDRESS: STREET 1: 4TH FLOOR, CONNAUGHT HOUSE STREET 2: ONE BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGill Iain CENTRAL INDEX KEY: 0001615764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33500 FILM NUMBER: 161470518 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS PLC STREET 2: 4TH FL, CONNAUGHT HOUSE, 1 BURLINGTON RD CITY: DUBLIN STATE: L2 ZIP: 4 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-02-25 0 0001232524 Jazz Pharmaceuticals plc JAZZ 0001615764 McGill Iain CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4 DUBLIN 4 L2 IRELAND 0 1 0 0 SVP, Europe & Rest of World Ordinary Shares 2016-02-25 4 A 0 4000.0 0.0 A 23146 D Ordinary Shares 2016-02-26 4 F 0 392.0 125.0 D 22754 D Non-Qualified Stock Option (right to buy) 123.36 2016-02-25 4 A 0 10000.0 0.0 A 2026-02-24 Ordinary Shares 10000 10000 D These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 25, 2016. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. By: /s/ Karen Eberle as attorney in fact For: Iain McGill 2016-02-29